Biolife Solutions (BLFS) Capital Expenditures (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Capital Expenditures data on file, last reported at $167000.0 in Q1 2026.

• On a quarterly basis, Capital Expenditures fell 69.75% year-over-year to $167000.0 in Q1 2026; TTM through Mar 2026 was $9.1 million, a 142.29% increase from a year earlier, with the FY2025 full-year figure at $9.5 million, up 193.71% from the prior year.
• Capital Expenditures for Q1 2026 stood at $167000.0, down from $4.3 million in the prior quarter.
• Over the last five years, Capital Expenditures for BLFS reached as high as $8.7 million in Q4 2022 and fell as low as -$2.5 million in Q2 2023.
• Historically, Capital Expenditures has averaged $1.7 million across 5 years, with a median of $762000.0 in 2024.
• On a YoY basis, Capital Expenditures climbed as much as 25246.15% in 2023 and fell as far as 2869.66% in 2023.
• Year by year, Capital Expenditures stood at $8.7 million in 2022, then sank by 73.44% to $2.3 million in 2023, then plunged by 67.11% to $762000.0 in 2024, then jumped by 458.79% to $4.3 million in 2025, then tumbled by 96.08% to $167000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $167000.0 in Q1 2026, $4.3 million in Q4 2025, and $5.1 million in Q3 2025.